Systematic Multi-domain Alzheimer's Risk Reduction Trial

NACompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

August 10, 2022

Study Completion Date

August 10, 2022

Conditions
DementiaAlzheimer Disease
Interventions
BEHAVIORAL

SMARRT Intervention

Interventionists will follow a standard protocol for delivering the SMARRT intervention that allows for personalization of the specific risk reduction action plan; these plans will evolve over time according to participant progress, motivation and preferences or newly identified risk factors. Staff will use a tracking database to record information for each participant, including session dates, identified risk factors, motivational barriers and important values, and the outcome of discussions around developing goals. For each participant, the exact number and mode (phone or in-person) of contacts will differ, but we will aim to have at least 1 contact per month with each participant. Best practice will include in-person meetings twice a year during the 2-year intervention period.

BEHAVIORAL

Health Education Intervention

Participants randomized to the Health Education (HE) group will receive mailed materials (typically 1-2 pages) every 3 months. This will include general information on Alzheimer's and dementia risk reduction using materials from sources such as the Alzheimer's Association and educational materials commonly provided as part of routine care at Kaiser Permanente Washington (KPWA).

Trial Locations (1)

98101

Kaiser Permanente Washington Health Research Institute, Seattle

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Kaiser Permanente

OTHER

NCT03683394 - Systematic Multi-domain Alzheimer's Risk Reduction Trial | Biotech Hunter | Biotech Hunter